Cardlytics, Inc.
DE ˙ DB ˙ US14161W1053
0,49 € ↓ -0,01 (-2,80%)
2026-06-04
AKTIENPREIS
SecurityDE:CYX / Cardlytics, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership65,556 shares
Latest Disclosed Value $ 68,834
Millennium Management Llc reports 74.27% decrease in ownership of CYX / Cardlytics, Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 65,556 shares of Cardlytics, Inc. (DE:CYX) valued at $48,551 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 254,737 shares of Cardlytics, Inc.. This represents a change in shares of -74.27% during the quarter. The current value of the position is $31,860 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CARDLYTICS COM 14161W105 65,556 -189,181 -74.27 69 -76.71 0.0000
2026-02-17 2025-12-31 13F CARDLYTICS COM 14161W105 254,737 -124,024 -32.74 293 -68.26 0.0001
2025-11-14 2025-09-30 13F CARDLYTICS COM 14161W105 378,761 -160,670 -29.79 920 3.72 0.0004
2025-08-14 2025-06-30 13F CARDLYTICS COM 14161W105 539,431 -166,206 -23.55 887 -30.92 0.0004
2025-05-15 2025-03-31 13F CARDLYTICS COM 14161W105 705,637 561,399 389.22 1,284 140.00 0.0007
2025-02-14 2024-12-31 13F CARDLYTICS COM 14161W105 144,238 144,238 535 0.0003
2024-08-14 2024-06-30 13F CARDLYTICS COM 14161W105 0 -54,860 -100.00 0 -100.00
2024-05-15 2024-03-31 13F CARDLYTICS COM 14161W105 54,860 -7,735 -12.36 795 37.85 0.0003
2024-02-14 2023-12-31 13F CARDLYTICS COM 14161W105 62,595 62,595 576 0.0002
2023-11-14 2023-09-30 13F CARDLYTICS COM 14161W105 0 -41,217 -100.00 0 -100.00
2023-08-14 2023-06-30 13F CARDLYTICS COM 14161W105 41,217 41,217 260 0.0001
2023-05-15 2023-03-31 13F CARDLYTICS COM 14161W105 0 -39,035 -100.00 0 -100.00
2023-02-14 2022-12-31 13F CARDLYTICS COM 14161W105 39,035 -90,625 -69.89 226 -81.46 0.0001
2022-11-14 2022-09-30 13F CARDLYTICS COM 14161W105 129,660 26,406 25.57 1,219 -47.09 0.0007
2022-08-15 2022-06-30 13F CARDLYTICS COM 14161W105 103,254 91,146 752.78 2,304 245.95 0.0014
2022-05-16 2022-03-31 13F CARDLYTICS COM 14161W105 12,108 1,683 16.14 666 -3.34 0.0004
2022-02-14 2021-12-31 13F CARDLYTICS COM 14161W105 10,425 3,028 40.94 689 10.95 0.0004
2021-11-15 2021-09-30 13F CARDLYTICS COM 14161W105 7,397 -12,055 -61.97 621 -74.85 0.0004
2021-08-16 2021-06-30 13F CARDLYTICS COM 14161W105 19,452 -13,245 -40.51 2,469 -31.17 0.0015
2021-05-17 2021-03-31 13F CARDLYTICS COM 14161W105 32,697 12,087 58.65 3,587 21.92 0.0026
2021-02-16 2020-12-31 13F CARDLYTICS COM 14161W105 20,610 -53,039 -72.02 2,942 -43.39 0.0021
2020-11-16 2020-09-30 13F CARDLYTICS COM 14161W105 73,649 73,649 5,197 0.0064
2020-08-14 2020-06-30 13F CARDLYTICS COM 14161W105 0 -9,756 -100.00 0 -100.00
2020-05-14 2020-03-31 13F CARDLYTICS COM 14161W105 9,756 -61,541 -86.32 341 -92.39 0.0008
2020-02-14 2019-12-31 13F CARDLYTICS COM 14161W105 71,297 -116,416 -62.02 4,482 -28.77 0.0056
2019-11-14 2019-09-30 13F CARDLYTICS COM 14161W105 187,713 121,608 183.96 6,292 266.45 0.0099
2019-08-15 2019-06-30 13F/A-1 CARDLYTICS COM 14161W105 66,105 66,105 1,717 0.0026
2019-08-14 2019-06-30 13F CENTRAL GARDEN & PET CL A NON-VTG 14161W105 422,153 422,153 10,402
2019-02-15 2018-12-31 13F/A-1 CARDLYTICS COM 14161W105 0 -36,325 -100.00 0 -100.00
2018-11-14 2018-09-30 13F CARDLYTICS COM 14161W105 36,325 -51,811 -58.79 910 -52.55 0.0011
2018-08-14 2018-06-30 13F CARDLYTICS COM 14161W105 88,136 -88,768 -50.18 1,918 -25.89 0.0025
2018-05-15 2018-03-31 13F CARDLYTICS COM 14161W105 176,904 176,904 2,588 0.0035
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.